Dysregulation of SIGLEC1 in non-small cell lung cancer: prognostic implications and immunomodulatory role-a multicenter cohort study. Liu Y, Lin W, Gu Y, Lu C, et al. J Cancer Res Clin Oncol 2024;150:481.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu Y, Lin W, Gu Y, Lu C, et al. Dysregulation of SIGLEC1 in non-small cell lung cancer: prognostic implications and immunomodulatory role-a multicenter cohort study. J Cancer Res Clin Oncol 2024;150:481.
PMID: 39470815